Tirzepatide Lyophilized High Purity 99% Peptide Powder TR 10mg 15mg 20mg 30mg ka vial bakeng sa tsoekere ea mali / lefu la tsoekere

Tirzepatide ke "insulinotropic polypeptide/glucagon-like peptide 1" (GLP-1) receptor agonist e amohetsoeng United States e le tlatsetso ea lijo le boikoetliso ho ntlafatsa taolo ea glycemic ho batho ba baholo ba nang le lefu la tsoekere la mofuta oa 2 le tlas'a lipatlisiso bakeng sa ts'ebeliso ea taolo ea boima bo sa foleng, liketsahalo tse mpe tsa pelo le ts'ebetso ea pelo le maemo a mang. non-cirrhotic non-alcohol steatohepatitis. Lenaneo la liteko tsa tleliniki tsa Phase 3 SURPASS 1-5 le ne le etselitsoe ho lekola katleho le polokeho ea tirzepatide e kentsoeng hang ka beke ka subcutaneous (5, 10 le 15 mg), e le monotherapy kapa kalafo e kopaneng, ho batho ba bangata ba nang le lefu la tsoekere la mofuta oa 2. Tšebeliso ea tirzepatide lithutong tsa bongaka e ile ea amahanngoa le phokotso e hlakileng ea hemoglobin ea glycated (-1.87 ho -2.59%, -20 ho -28 mmol / mol) le boima ba 'mele (-6.2 ho -12.9 lik'hilograma), hammoho le phokotso ea litekanyetso tse amanang le kotsi e ntseng e eketseha ea pelo e kang khatello ea mali, triglycerides le "visceride" Tirzepatide e ile ea mamelloa hantle, e na le kotsi e tlase ea hypoglycemia ha e sebelisoa ntle le insulin kapa insulin secretagogues mme e bonts'a boemo bo ts'oanang ba polokeho ho sehlopha sa li-agonists tsa GLP-1. Ka hona, bopaki bo tsoang litekong tsena tsa bongaka bo fana ka maikutlo a hore tirzepatide e fana ka monyetla o mocha oa ho theola hemoglobin ea glycated le boima ba 'mele ho batho ba baholo ba nang le lefu la tsoekere la mofuta oa 2.